Compound Summary
Compound Information
ENOXIMONE
Compound Name: | ENOXIMONE |
Compound CID: | 53708 |
Synonyms: | ENOXIMONE 77671-31-9 Perfan Fenoximone MDL-17043 More... |
Iupac Name: | 4-methyl-5-(4-methylsulfanylbenzoyl)-1,3-dihydroimidazol-2-one |
InChI: | InChI=1S/C12H12N2O2S/c1-7-10(14-12(16)13-7)11(15)8-3-5-9(17-2)6-4-8/h3-6H,1-2H3,(H2,13,14,16) |
InChIKey: | ZJKNESGOIKRXQY-UHFFFAOYSA-N |
Canonical Smiles: | CC1=C(NC(=O)N1)C(=O)C2=CC=C(C=C2)SC |
Isomeric Smiles: | CC1=C(NC(=O)N1)C(=O)C2=CC=C(C=C2)SC |
Molecular Weight: | 248.3 |
Molecular Formula: | C12H12N2O2S |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
ENOXIMONE
Molecular Weight: | 248.3 |
Molecular Formula: | C12H12N2O2S |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 3 |
Heavy Atom Count: | 17 |
Complexity: | 371 |
Synonyms
ENOXIMONE
| ENOXIMONE | ENOXIMONE |
|---|---|
ENOXIMONE |
77671-31-9 |
Perfan |
Fenoximone |
MDL-17043 |
MDL 17,043 |
4-methyl-5-(4-methylsulfanylbenzoyl)-1,3-dihydroimidazol-2-one |
UNII-C7Z4ITI7L7 |
RMI-17043 |
C7Z4ITI7L7 |
CHEMBL249856 |
2H-Imidazol-2-one, 1,3-dihydro-4-methyl-5-(4-(methylthio)benzoyl)- |
Enoximonum Latin |
NCGC00015400-02 |
Enoximona Spanish |
Enoximona |
Enoximonum |
1,3-Dihydro-4-methyl-5-4-methylthiobenzoyl-2H-imidazol-2-one |
DSSTox_CID_25147 |
DSSTox_RID_80702 |
DSSTox_GSID_45147 |
Perfane |
1,3-Dihydro-4-methyl-5-(4-methylthiobenzoyl)-2H-imidazol-2-one |
2H-Imidazol-2-one, 1,3-dihydro-4-methyl-5-4-(methylthio)benzoyl- |
SMR000857318 |
MDL-17,043 |
CAS-77671-31-9 |
Perfan (TN) |
Enoximone (USAN/INN) |
Enoximone USAN:INN:BAN |
4-Methyl-5-(p-(methylthio)benzoyl)-4-imidazolin-2-one |
Enoximone, solid |
Lopac-E-1279 |
E 1279 |
Lopac0_000410 |
SCHEMBL44049 |
MLS001335963 |
MLS001335964 |
MLS002172494 |
GTPL9063 |
SCHEMBL5702510 |
DTXSID8045147 |
CHEBI:135010 |
HMS2234C20 |
HMS3261A22 |
HMS3369O01 |
BCP04265 |
EX-A3632 |
HY-B1639 |
ZINC9225358 |
Tox21_110137 |
Tox21_500410 |
1,3-Dihydro-4-methyl-5-4-(methylthio)benzoyl-2H-imidazol-2-one |
BDBM50241379 |
MFCD00867130 |
AKOS005145769 |
Tox21_110137_1 |
AC-3396 |
CCG-204503 |
DB04880 |
LP00410 |
SDCCGSBI-0050396.P002 |
NCGC00015400-01 |
NCGC00015400-03 |
NCGC00015400-04 |
NCGC00015400-05 |
NCGC00015400-10 |
NCGC00093835-01 |
NCGC00093835-02 |
NCGC00261095-01 |
K360 |
DB-056240 |
B6833 |
CS-0013589 |
EU-0100410 |
FT-0630855 |
D04004 |
671E319 |
A848234 |
SR-01000075850 |
Q5379471 |
SR-01000075850-1 |
4-methyl-5-(4-(methylthio)benzoyl)-1H-imidazol-2(3H)-one |
5-methyl-4-(4-(methylthio)benzoyl)-1H-imidazol-2(3H)-one |
4-Methyl-5-(4-methylsulfanyl-benzoyl)-1,3-dihydro-imidazol-2-one |
4-methyl-5-4-(methylsulfanyl)benzoyl-1,3-dihydro-2H-imidazol-2-one |
(enoximone)4-Methyl-5-(4-methylsulfanyl-benzoyl)-1,3-dihydro-imidazol-2-one |
4-Methyl-5-(4-methylsulfanyl-benzoyl)-1,3-dihydro-imidazol-2-one (Enoximone) |
4-Methyl-5-(4-methylsulfanyl-benzoyl)-1,3-dihydro-imidazol-2-one(Enoximone) |
4-Methyl-5-(4-methylsulfanyl-benzoyl)-1,3-dihydro-imidazol-2-one(fenoximone, MDL-17043) |
4-methyl-5-{4-(methylsulfanyl)phenylcarbonyl}-2,3-dihydro-1H-imidazol-2-one |
Experimental Data
ENOXIMONE
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | -10 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
ENOXIMONE
Statistics Data
ENOXIMONE
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -10 | 1 | 1 |
Statistics Data Visualization
ENOXIMONE
